美国 · SEC FORM 4
Bolt Biotherapeutics, Inc.
BOLT · Nasdaq · CIK 0001641281 · Healthcare · Biotechnology
内部人信号
2 qualifying P purchase groups
当前 180 天评分窗口
11 同一窗口内观察到的 Form 4 交易行
9 sales · 0 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度与集中度
Roles in the peak window: President, CEO and CFO, Senior VP, Finance and PAO. Concentration uses priced qualifying P lines only and does not change the saved score.
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-06-05 · Nemec Sarah.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 25,736
- 上期报告
- 18,486
- 日均成交量
- 42,277
- 回补天数
- ≤ 1.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Quinn William P. | 买入 (P) | Common Stock | 637 | USD 3.88 | USD 2,472 | SEC 申报 ↗ |
| 2026-06-05 | Nemec Sarah | 买入 (P) | Common Stock | 509 | USD 3.88 | USD 1,975 | SEC 申报 ↗ |
| 2025-12-05 | Quinn William P. | 买入 (P) | Common Stock | 125 | USD 4.61 | USD 576 | SEC 申报 ↗ |
| 2025-12-05 | Nemec Sarah | 买入 (P) | Common Stock | 125 | USD 4.61 | USD 576 | SEC 申报 ↗ |
| 2025-06-06 | Quinn William P. | 买入 (P) | Common Stock | 125 | USD 5.49 | USD 686 | SEC 申报 ↗ |
| 2025-06-06 | Nemec Sarah | 买入 (P) | Common Stock | 125 | USD 5.49 | USD 686 | SEC 申报 ↗ |
| 2024-12-16 | Quinn William P. | 买入 (P) | Common Stock | 2,500 | USD 0.50 | USD 1,250 | SEC 申报 ↗ |
| 2024-12-16 | Nemec Sarah | 买入 (P) | Common Stock | 2,500 | USD 0.50 | USD 1,250 | SEC 申报 ↗ |
| 2024-06-06 | Quinn William P. | 买入 (P) | Common Stock | 2,500 | USD 0.64 | USD 1,600 | SEC 申报 ↗ |
| 2024-06-06 | Nemec Sarah | 买入 (P) | Common Stock | 2,500 | USD 0.64 | USD 1,600 | SEC 申报 ↗ |
| 2023-12-12 | Quinn William P. | 买入 (P) | Common Stock | 7,500 | USD 0.95 | USD 7,125 | SEC 申报 ↗ |
| 2023-12-06 | Yonehiro Grant | 买入 (P) | Common Stock | 2,500 | USD 0.78 | USD 1,950 | SEC 申报 ↗ |
| 2023-12-06 | Schatzman Randall C | 买入 (P) | Common Stock | 2,500 | USD 0.78 | USD 1,950 | SEC 申报 ↗ |
| 2023-12-06 | Perez Edith A. | 买入 (P) | Common Stock | 2,500 | USD 0.78 | USD 1,950 | SEC 申报 ↗ |
| 2023-12-06 | Quinn William P. | 买入 (P) | Common Stock | 2,500 | USD 0.78 | USD 1,950 | SEC 申报 ↗ |
Form 4 申报证据
16 transaction lines in the latest 365-day window; 115 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | Yonehiro Grant | 卖出 (S) | Common Stock | 6,850 | USD 3.24 | USD 22,194 | SEC 申报 ↗ |
| 2026-09-18 | Quinn William P. | 卖出 (S) | Common Stock | 9,132 | USD 3.24 | USD 29,588 | SEC 申报 ↗ |
| 2026-09-18 | Nemec Sarah | 卖出 (S) | Common Stock | 4,077 | USD 3.24 | USD 13,209 | SEC 申报 ↗ |
展开近期 Form 4 证据 (16 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | Yonehiro Grant | 卖出 (S) | Common Stock | 6,850 | USD 3.24 | USD 22,194 | SEC 申报 ↗ |
| 2026-09-18 | Quinn William P. | 卖出 (S) | Common Stock | 9,132 | USD 3.24 | USD 29,588 | SEC 申报 ↗ |
| 2026-09-18 | Nemec Sarah | 卖出 (S) | Common Stock | 4,077 | USD 3.24 | USD 13,209 | SEC 申报 ↗ |
| 2026-09-17 | Yonehiro Grant | 卖出 (S) | Common Stock | 4,909 | USD 3.32 | USD 16,298 | SEC 申报 ↗ |
| 2026-09-17 | Quinn William P. | 卖出 (S) | Common Stock | 6,545 | USD 3.32 | USD 21,729 | SEC 申报 ↗ |
| 2026-09-17 | Nemec Sarah | 卖出 (S) | Common Stock | 2,922 | USD 3.32 | USD 9,701 | SEC 申报 ↗ |
| 2026-09-16 | Yonehiro Grant | 卖出 (S) | Common Stock | 1,417 | USD 3.77 | USD 5,342 | SEC 申报 ↗ |
| 2026-09-16 | Quinn William P. | 卖出 (S) | Common Stock | 1,889 | USD 3.77 | USD 7,122 | SEC 申报 ↗ |
| 2026-09-16 | Nemec Sarah | 卖出 (S) | Common Stock | 843 | USD 3.77 | USD 3,178 | SEC 申报 ↗ |
| 2026-06-05 | Quinn William P. | 买入 (P) | Common Stock | 637 | USD 3.88 | USD 2,472 | SEC 申报 ↗ |
| 2026-06-05 | Nemec Sarah | 买入 (P) | Common Stock | 509 | USD 3.88 | USD 1,975 | SEC 申报 ↗ |
| 2025-12-05 | Quinn William P. | 买入 (P) | Common Stock | 125 | USD 4.61 | USD 576 | SEC 申报 ↗ |
| 2025-12-05 | Nemec Sarah | 买入 (P) | Common Stock | 125 | USD 4.61 | USD 576 | SEC 申报 ↗ |
| 2025-10-22 | Yonehiro Grant | 奖励／授予 (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-10-22 | Quinn William P. | 奖励／授予 (A) | Common Stock | 40,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-10-22 | Nemec Sarah | 奖励／授予 (A) | Common Stock | 23,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | BOLT |
| CIK | 0001641281 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 115 transaction lines from 2021-02-09 to 2026-09-18 44 P purchase lines · 40 S sale lines · 31 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.